Balancing High Production & Quality in Biopharmaceutical Generation
In therapeutic protein production, the ability to determine the right end-point for mammalian cell culture lets researchers minimize HCP (host-cell protein) contamination.
We're Moving to
The content you are trying to access has moved to new site. Explore, discover (and in certain contries, buy) our products and services on our new website. Click to visit now or you will be automatically redirected.
to view non-migrated solutions
In therapeutic protein production, the ability to determine the right end-point for mammalian cell culture lets researchers minimize HCP (host-cell protein) contamination.
Using a state-of-the-art antibody technology platform, AIMM develops desperately needed therapeutics to improve treatment of inflammatory, autoimmune and infectious diseases.
Streamline multiple, manual steps of slab gel electrophoresis, while attaining rapid, reproducible data viewed as a virtual gel, electropherogram, or tabular display.
Our Alpha technology provides a unique beads-based platform that combines convenience, optimal performance, and superior flexibility.
实验室研究人员和科学家从疾病治疗研究过程中获得更深入见解,进一步为新药和疗法探索提供经验基础。
我们提供全面、创新的解决方案,确保一致、稳定的实验结果,同时满足生物制药研究人员和病人的安全需求。